Shanghai Hengrui Pharmaceutical Co., Ltd.

This study tests a new drug called SHR-A1904 against standard treatments for people with advanced stomach or gastroesophageal junction cancer that has gotten worse after first treatment. The drug targets a protein called CLDN18.2 found on some cancer cells. About 524 adults aged …

This study tests a new drug called SHR-7367 combined with other anti-cancer medicines in people with advanced solid tumors. The goal is to find the safest dose and see if the combination can shrink tumors. About 100 adults aged 18-75 with good organ function and at least one meas…

This study tests a new drug, HRS-4642, combined with other cancer treatments for people with advanced pancreatic cancer that cannot be removed by surgery. About 60 adults aged 18-75 will take part to see if the combination is safe and helps control the disease longer. The goal is…

This study tests a new drug called SHR-7787 combined with other cancer treatments in people with advanced solid tumors that cannot be removed by surgery. The goal is to find safe doses and see if the combination shrinks tumors or slows cancer growth. About 400 adults with various…

This study tests a new drug called SHR-9839, given with other cancer treatments, for people with advanced solid tumors that have spread. The goal is to see if the combination is safe and helps shrink tumors. About 156 adults aged 18-75 with certain cancers like lung cancer will t…

This study tests a new drug called SHR-A2102 combined with other cancer treatments for people with a type of lung cancer that can be removed with surgery. The goal is to see if the combination works better than standard care at shrinking tumors before surgery and preventing cance…

This study tests two experimental drugs, SHR-1501 and adbelizumab, together in people with advanced or metastatic solid tumors that have not responded to standard treatments. The goal is to find the safest dose and see if the combination can shrink tumors. About 203 participants …

This study tests a new drug (SHR-A2102) combined with another drug (adebrelimab) for people with advanced or metastatic non-small cell lung cancer. The goal is to find the safest and most effective dose and see if the combination shrinks tumors. About 248 adults aged 18-70 with m…

This study is for people with advanced solid tumors that have a protein called CLDN18.2. It tests a new drug (SHR-A1904) combined with chemotherapy and immunotherapy to see if it is safe and works better than standard treatment. The goal is to control the disease, not cure it, an…

This early-stage study tests an experimental pain drug called HRS-6257 in 80 healthy volunteers aged 18-55. The main goal is to check safety and side effects, and to see how the body processes the drug with and without food. Participants will receive either the drug or a placebo,…